University of Montreal
$300,000.00 CAD
- Department
- Canadian Space Agency
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- March 21, 2024 – December 31, 2026
- Reference
- csa-asc:003-2023-2024-Q4-00067
Published purpose
This project is intended to validate a portable technology based on surface plasmon resonance and passively pumped microfluidic techniques for disease screening in mobile clinics, remote regions and in space. We will also train a generation of scientists capable of meeting the challenges of remote site health care. The research proposed in this project will lead to multiple benefits for Canada, including the availability of disease detection technology that works in remote communities, the strengthening of Canada's position as a leader in the development of space technologies, and the contribution to the development of commercial activities in this sector in Canada.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.